ArticleScientific reports2025
Clinical benefits of the 5th intercostal incision in uniportal VATS for female patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To assess the clinical benefits of a 5th versus 4th intercostal incision in female patients undergoing uniportal video-assisted thoracoscopic surgery (VATS) lobectomy and lymphadenectomy, focusing on breast tissue preservation, pain, cosmetic outcomes, recovery, and surgical maneuverability. A retrospective analysis of 150 female lung cancer patients was conducted, divided into 4 and 5th intercostal incision groups (n = 75 each). Propensity score matching balanced baseline characteristics. Primary outcomes included breast tissue involvement, postoperative pain (VAS), cosmetic satisfaction (Likert scale), recovery time, surgical maneuverability, and complication rates. Statistical analysis used Mann-Whitney U and Chi-square tests for group comparisons and multivariable regression to adjust for confounders. The 5th intercostal incision significantly reduced breast tissue involvement (10.7 vs. 65.3%, p < 0.01), postoperative pain (VAS: 4.8 vs. 7.2, p < 0.01), and recovery time (5.9 vs. 8.4 days, p < 0.05), while enhancing cosmetic satisfaction (p < 0.01) and improving access to upper pulmonary veins. Incision site infections were notably lower in the 5th intercostal group (2.7 vs. 10.7%, p < 0.05). The 5th intercostal incision provides substantial clinical advantages in uniportal VATS for female patients, including reduced breast tissue involvement, minimized pain, enhanced cosmetic outcomes, and faster recovery. These findings support the 5th intercostal incision as a preferred approach in this patient population, aligning with precision surgery principles to optimize outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.